Merck & Co., Inc. (NYSE: MRK) is recovering from the virus-induced slowdown supported by stable demand across its product line globally, a
Is Merck & Co. (MRK) a good investment after Q1 earnings?
Categories
pharmaceuticals
Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens
Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a widder net loss for the first quarter of 2022 despite a 6%
Infographic: Highlights of Merck’s (MRK) Q1 2022 earnings
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The positive outcome
Biogen’s (BIIB) long-term prospects look intact despite Alzheimer’s drug setback
Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition and the
Stock Watch: Should you invest in Eli Lilly (LLY) after Q1 earnings?
For Eli Lilly and Company (NYSE: LLY), 2021 was a fruitful year in terms of financial performance and product development. Reflecting the
Pfizer (PFE) anticipates an increase in orders for Paxlovid in coming months due to virus mutations
Shares of Pfizer Inc. (NYSE: PFE) gained nearly 2% on Tuesday after the company delivered better-than-expected results for the first quarter of
Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It helps independent
PFE Earnings: All you need to know about Pfizer’s Q1 2022 earnings results
Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported net income
Earnings: Highlights of Eli Lilly’s (LLY) Q1 2022 results
Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers also surpassed
Infographic: Highlights of Intuitive Surgical’s Q1 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in revenues, hurt
Abbott Laboratories (ABT) Q1 2022 Infographic: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for the first
Johnson & Johnson (JNJ) reports Q1 2022 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
AngioDynamics (ANGO) Q3 earnings beat estimates as sales increase
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's net sales
Infographic: Highlights of Cronos’ (CRON) Q4 2021 earnings report
Cronos Group Inc. (NASDAQ: CRON) has reported a wider net loss for the fourth quarter of 2021, despite a double-digit increase in
Infographic: How Tilray (TLRY) performed in Q3 2022
Tilray (NASDAQ: TLRY) reported third-quarter 2022 financial results before the regular market hours on Wednesday. Total net revenue increased 23% year-over-year to
Trxade will stay focused on traditional technology platform for margin growth: CEO Suren Ajjarapu
[caption id="attachment_135351" align="alignnone" width="1280"] Image: iStock[/caption] Can you briefly talk about your business model and the value you add to the market?
Why Intuitive Surgical (ISRG) is a must-own stock after the recent dip
The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities into overdrive,
HEXO Earnings: Highlights of Hexo’s Q2 2022 financial results
Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the Canada-based company's
Cipher Pharmaceuticals Inc. (CPH) Q4 2021 Earnings Call Transcript
Cipher Pharmaceuticals, Inc. ( TSX: CPH) Q4 2021 earnings call dated Mar. 18, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott
Should you invest in Walgreens Boots Alliance ahead of earnings?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been busy enhancing its capabilities in healthcare delivery lately, through various initiatives including M&A deals.
ANI Pharmaceuticals, Inc. (ANIP) Q4 2021 Earnings Call Transcript
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q4 2021 earnings call dated Mar. 15, 2022 Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and Chief